Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Preclinical Diastolic Dysfunction and Renal Dysfunction
NCT02058095Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in diastolic dysfunction, renal impairment (RI), sponsored by Mayo Clinic. Started Mar 2014; status: completed.
02
Drugs
tadalafil
03
Conditions
diastolic dysfunctionrenal impairment (RI)
Beyond the preview
Go deeper on NCT02058095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058095.